Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Laure Hitzel is active.

Publication


Featured researches published by Laure Hitzel.


Pharmaceutical Research | 2000

An Increased Throughput Method for the Determination of Partition Coefficients

Laure Hitzel; Alan P. Watt; Karen L Locker

AbstractPurpose. To present an increased throughput automated shake-flask method for the direct determination of the partition coefficients of solutes between octan-1-ol and buffer. Method. The traditional shake-flask method has been transferred onto 96-well plate technology and a robotic liquid handler has been used for sample preparation. A custom programmed Gilson auto- sampler samples the organic and aqueous phases directly from the plate, circumventing the need for any manual separation. Analyses are performed by reverse phase high performance liquid chromatography (RP-HPLC). Generic fast gradient RP-HPLC conditions are used to eliminate chromatographic method development time and reduce analysis time. Results. A full validation of the automated method is presented for a range of compounds with log D values between −2 and 4. Conclusions. The advantages and limitations of this direct measurement method are discussed. The use of this methodology provides a means to rapidly assess log D values for large compound arrays.


Bioorganic & Medicinal Chemistry Letters | 1999

Parallel synthesis of 3-aryloxy-2-propanolamines and evaluation as dual affinity 5-HT1A and 5-HT re-uptake ligands

Monique Bodil Van Niel; Margaret S. Beer; JoséL. Castro; Susan K. F. Cheng; David C. Evans; Anne Heald; Laure Hitzel; Peter Hunt; Russell J. Mortishire-Smith; Desmond O'Connor; Alan P. Watt; Angus Murray Macleod

A solution phase synthesis for the preparation of 3-aryloxy-2-propanolamine libraries has been developed. This resulted in the identification of 5 as a ligand with dual affinity for 5-HT1A and serotonin reuptake receptors which shows excellent pharmacokinetic parameters.


Journal of Chromatography A | 2000

Determination of the in vitro metabolism of (+)- and (−)-epibatidine

Alan P. Watt; Laure Hitzel; Denise Morrison; Karen L Locker

The oxidative in vitro metabolism of epibatidine was investigated using liver microsomes from rat, dog, rhesus monkey and human. Analysis was performed using liquid chromatography-mass spectrometry (LC-MS) using both achiral and chiral stationary phases. Comparison of the metabolism of the (+)- and (-)-enantiomers revealed species differences in the extent of metabolism, with rhesus monkey>dog>rat=human. Furthermore, differences in the routes of metabolism for epibatidine enantiomers were also observed, with mass spectra consistent with hydroxylation of the azabicycle for (-)-epibatidine and with the formation of diastereomeric N-oxides for (+)-epibatidine being obtained. For chiral LC-MS, a volatile ion-pair reagent of heptafluorobutyric acid was used in place of pentanesulphonic acid with no deterioration in chiral selectivity. Analysis of the same samples by chiral LC-MS revealed no evidence for metabolic chiral interconversion and chiral analysis from a metabolic time course of racemic material revealed enantiomers to be metabolised to approximately the same extent. Such findings may be important particularly should epibatidine be investigated in non-rodent species.


Journal of Chromatography A | 2000

Use of chiral liquid chromatography-tandem mass spectrometry to investigate the metabolism of racemic cholecystokinin-B antagonists

Alan P. Watt; Laure Hitzel; Denise Morrison; Karen L Locker

In an attempt to establish the enantiomeric specificity of metabolism for a series of racemic cholecystokinin-B receptor antagonists, chiral LC-MS-MS conditions were established using a Pirkle DNBL chiral stationary phase operating in the reversed-phase mode. Rat liver microsomal incubations of the compounds were analysed using these conditions and it was demonstrated that resolution of oxygenated and demethylated metabolites could be achieved. A single model compound was investigated in detail by obtaining product-ion spectra on all mono-oxygenated species in an attempt to correlate these and identify enantiomeric pairs of metabolites. In this example a lack of differentiation in the product ion spectra did not allow correlation but the results suggest that such an approach may still be viable for the chiral metabolic analysis of racemic material.


Journal of Biochemical and Biophysical Methods | 2002

Enantiomeric separation of substituted 2-arylindoles on derivatised polysaccharide chiral stationary phases

Alan P. Watt; Laure Hitzel; Russell J. Mortishire-Smith

The enantiomeric separation of a series of 2-arylindoles, developed as 5HT(2A) receptor antagonists for the treatment of schizophrenia, was investigated. Evaluation of a number of chiral stationary phases (CSPs) suggested that Chiralcel OD-H and Chiralpak AD were the most versatile for these compounds, and were employed for more detailed studies. A degree of complementarity between the CSPs was observed, such that Chiralcel OD-H was more effective for piperidine-containing molecules and Chiralpak AD for piperazine- and morpholine-containing molecules. The presence of a basic secondary amine was detrimental chromatographically, but resolution was improved substantially by employing diethylamine (DEA) in the mobile phase. All separations were either enthalpy-controlled or showed no temperature dependence. Differential temperature effects between series highlighted the possibility of multiple binding modes on these CSPs. Based on this study, it is possible to make a more rational selection of chromatographic conditions for future novel analogues.


Journal of Liquid Chromatography & Related Technologies | 2000

Chiral separation of 4,4-disubstituted piperidinyl substance P antagonists

Alan P. Watt; Laure Hitzel

The chiral separation of fourteen Substance P antagonists, substituted at a benzylic carbon to generate a chiral centre, was investigated using Chiracel OD-H and Chiralpak AD stationary phases. The nature of an N-substituent, distant from the chiral centre, was found to modulate separation selectivity. Aromatic substitution on the benzyl group also affected separation selectivity, but to a lesser degree. Some complementary character between Chiracel OD-H and Chiralpak AD was seen, but selection of the optimal phase did not appear predictable. The effect of temperature was also unanticipated, with some compounds showing the expected decrease of separation selectivity with temperature, whereas, an example of an improvement in separation selectivity with temperature to give an entropically controlled separation was also observed. This serves to highlight the complex nature of enantioselective interactions using chiral polymers and suggests that, given an unknown compound in this series, adequate separation conditions are difficult to predict.


Journal of Medicinal Chemistry | 2001

3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT2A receptor antagonists

Michael Rowley; David James Hallett; Simon Charles Goodacre; Christopher Richard Moyes; James Michael Crawforth; Timothy Jason Sparey; Smita Patel; Rose Marwood; Shil Patel; Steven Thomas; Laure Hitzel; Desmond O'Connor; Nicola Szeto; José L. Castro; Peter H. Hutson; Angus Murray Macleod


Bioorganic & Medicinal Chemistry Letters | 2006

4-Substituted cyclohexyl sulfones as potent, orally active γ-secretase inhibitors

Ian Churcher; Dirk Beher; Jonathan D. Best; José L. Castro; Earl E. Clarke; Amy Gentry; Timothy Harrison; Laure Hitzel; Euan Kay; Sonia Kerrad; Huw D. Lewis; Pablo Morentin-Gutierrez; Russell J. Mortishire-Smith; Paul Joseph Oakley; Michael Reilly; Duncan E. Shaw; Mark S. Shearman; Martin Richard Teall; Susie Williams; Jonathan D.J. Wrigley


Journal of Organic Chemistry | 2002

Synthesis and conformational dynamics of tricyclic pyridones containing a fused seven-membered ring

Karl Richard Gibson; Laure Hitzel; Russell J. Mortishire-Smith; Ute Gerhard; Richard Alexander Jelley; Austin John Reeve; Michael Rowley; and Alan Nadin; Andrew Pate Owens


Journal of Medicinal Chemistry | 1999

3-[3-(Piperidin-1-yl)propyl]indoles as Highly Selective h5-HT1D Receptor Agonists

Michael Geoffrey Neil Russell; Victor Giulio Matassa; Roy R. Pengilley; Monique B. van Niel; Bindi Sohal; Alan P. Watt; Laure Hitzel; Margaret S. Beer; and Howard B. Broughton; José L. Castro

Researchain Logo
Decentralizing Knowledge